President Donald Trump announced on Oct. 10 an agreement with AstraZeneca to lower drug prices in the United States.
The U.K.-based pharmaceutical manufacturer will offer most-favored-nation drug pricing on all medications to Medicaid recipients, guaranteeing them the lowest price available in any developed country.
AstraZeneca will also offer many medications at heavily discounted rates through TrumpRx.gov, which is expected to launch early next year.
Trump made the announcement alongside AstraZeneca CEO Pascal Soriot and senior administration officials, including Health Secretary Robert F. Kennedy Jr., and Virginia Gov. Glenn Youngkin.
AstraZeneca will also invest $50 billion in drug manufacturing, research, and development in the United States, including a facility in Charlottesville, Virginia, that is expected to provide 3,600 jobs…., 2025-10-10 21:48:00, 
, US Politics, %%, https://www.theepochtimes.com/us/us-politics/feed?, Lawrence Wilson
